Novartis makes a $12BN bid for Avidity Acquisition
Post# of 158166
(Total Views: 218)
Posted On: 10/26/2025 3:58:21 PM
Novartis makes a $12BN bid for Avidity Acquisition...this gives Novartis several drugs NEAR filing with the FDA.
Drugs candidates cover;
Myotonic Dystrophy type1 (DM1) effects about 140,000 in the USA.
Duchenne Muscular Dystrophy (DMD) effects about 15,000 in the USA.
Facioscapulhumeral Muscular Dystrophy (FSHD) about 15,000 in the USA.
Total Addressable Market for All (3) is about 170,000.
(m)TNBC TAM is about 275,000 in the USA.
CRC TAM is about 154,000 in the USA.
Do these Stats help Us in the (Leronlimab) Evaluations department?
Drugs candidates cover;
Myotonic Dystrophy type1 (DM1) effects about 140,000 in the USA.
Duchenne Muscular Dystrophy (DMD) effects about 15,000 in the USA.
Facioscapulhumeral Muscular Dystrophy (FSHD) about 15,000 in the USA.
Total Addressable Market for All (3) is about 170,000.
(m)TNBC TAM is about 275,000 in the USA.
CRC TAM is about 154,000 in the USA.
Do these Stats help Us in the (Leronlimab) Evaluations department?
(2)
(0)